TY - JOUR AU - Kurumbail, R. G. AU - Kiefer, J. R. AU - Marnett, L. J. PY - 2001 DA - 2001// TI - Cyclooxygenase enzymes: catalysis and inhibition JO - Curr Opin Struct Biol VL - 11 UR - https://doi.org/10.1016/S0959-440X(01)00277-9 DO - 10.1016/S0959-440X(01)00277-9 ID - Kurumbail2001 ER - TY - JOUR AU - Okamoto, T. AU - Hino, O. PY - 2000 DA - 2000// TI - Expression of cyclooxygenase-1 and -2 mRNA in rat tissues: tissue-specific difference in the expression of the basal level of mRNA JO - Int J Mol Med VL - 6 ID - Okamoto2000 ER - TY - JOUR AU - Seibert, K. AU - Zhang, Y. AU - Leahy, K. AU - Hauser, S. AU - Masferrer, J. AU - Perkins, W. PY - 1994 DA - 1994// TI - Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain JO - Proc Natl Acad Sci U S A VL - 91 UR - https://doi.org/10.1073/pnas.91.25.12013 DO - 10.1073/pnas.91.25.12013 ID - Seibert1994 ER - TY - JOUR AU - Teismann, P. AU - Tieu, K. AU - Choi, D. AU - Wu, D. AU - Naini, A. AU - Hunot, S. PY - 2003 DA - 2003// TI - Cyclooxygenase-2 is instrumental in parkinson’s disease neurodegeneration JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.0837397100 DO - 10.1073/pnas.0837397100 ID - Teismann2003 ER - TY - JOUR AU - Méric, J. AU - Rottey, S. AU - Olaussen, K. AU - Soria, J. AU - Khayat, D. AU - Rixe, O. PY - 2006 DA - 2006// TI - Cyclooxygenase-2 as a target for anticancer drug development JO - Crit Rev Oncol VL - 59 UR - https://doi.org/10.1016/j.critrevonc.2006.01.003 DO - 10.1016/j.critrevonc.2006.01.003 ID - Méric2006 ER - TY - JOUR AU - Shi, S. AU - Klotz, U. PY - 2008 DA - 2008// TI - Clinical use and pharmacological properties of selective COX-2 inhibitors JO - Eur J Clin Pharmacol VL - 64 UR - https://doi.org/10.1007/s00228-007-0400-7 DO - 10.1007/s00228-007-0400-7 ID - Shi2008 ER - TY - JOUR AU - FitzGerald, G. A. PY - 2004 DA - 2004// TI - Coxibs and cardiovascular disease JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMp048288 DO - 10.1056/NEJMp048288 ID - FitzGerald2004 ER - TY - JOUR AU - Cannon, C. P. AU - Cannon, P. J. PY - 2012 DA - 2012// TI - COX-2 inhibitors and cardiovascular risk JO - Science VL - 336 UR - https://doi.org/10.1126/science.1224398 DO - 10.1126/science.1224398 ID - Cannon2012 ER - TY - JOUR AU - Yu, Y. AU - Ricciotti, E. AU - Scalia, R. AU - Tang, S. Y. AU - Grant, G. AU - Yu, Z. AU - Landesberg, G. PY - 2012 DA - 2012// TI - Vascular COX-2 modulates blood pressure and thrombosis in mice JO - Sci Transl Med VL - 4 ID - Yu2012 ER - TY - JOUR AU - Edwards, J. AU - Mukherjee, R. AU - Munro, A. F. AU - Wells, A. C. AU - Almushatat, A. AU - Bartlett, J. M. S. PY - 2004 DA - 2004// TI - HER2 and COX2 expression in human prostate cancer JO - Eur J Cancer VL - 40 UR - https://doi.org/10.1016/j.ejca.2003.08.010 DO - 10.1016/j.ejca.2003.08.010 ID - Edwards2004 ER - TY - JOUR AU - Wang, D. AU - DuBois, R. N. PY - 2010 DA - 2010// TI - The role of COX-2 in intestinal inflammation and colorectal cancer JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2009.421 DO - 10.1038/onc.2009.421 ID - Wang2010 ER - TY - JOUR AU - Hwang, D. AU - Scollard, D. AU - Byrne, J. AU - Levine, E. PY - 1998 DA - 1998// TI - Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer JO - J Natl Cancer Inst VL - 90 UR - https://doi.org/10.1093/jnci/90.6.455 DO - 10.1093/jnci/90.6.455 ID - Hwang1998 ER - TY - JOUR AU - Jiménez, P. AU - García, A. AU - Santander, S. AU - Piazuelo, E. PY - 2007 DA - 2007// TI - Prevention of cancer in the upper gastrointestinal tract with COX-inhibition, still an option? JO - Curr Pharm Des VL - 13 UR - https://doi.org/10.2174/138161207781368800 DO - 10.2174/138161207781368800 ID - Jiménez2007 ER - TY - JOUR AU - Greenhough, A. AU - Smartt, H. AU - Moore, A. AU - Roberts, H. AU - Williams, A. AU - Paraskeva, C. PY - 2009 DA - 2009// TI - The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment JO - Carcinogenesis VL - 30 UR - https://doi.org/10.1093/carcin/bgp014 DO - 10.1093/carcin/bgp014 ID - Greenhough2009 ER - TY - JOUR AU - Ghosh, N. AU - Chaki, R. AU - Mandal, V. AU - Mandal, S. PY - 2010 DA - 2010// TI - COX-2 as a target for cancer chemotherapy JO - Pharmacol Rep VL - 62 UR - https://doi.org/10.1016/S1734-1140(10)70262-0 DO - 10.1016/S1734-1140(10)70262-0 ID - Ghosh2010 ER - TY - JOUR AU - Inoue, H. AU - Taba, Y. AU - Miwa, Y. AU - Yokota, C. AU - Miyagi, M. AU - Sasaguri, T. PY - 2002 DA - 2002// TI - Transcriptional and posttranscriptional regulation of cyclooxygenase-2 expression by fluid shear stress in vascular endothelial cells JO - Arterioscler Thromb Vasc Biol VL - 22 UR - https://doi.org/10.1161/01.ATV.0000028816.13582.13 DO - 10.1161/01.ATV.0000028816.13582.13 ID - Inoue2002 ER - TY - JOUR AU - Tietz, O. AU - Marshall, A. AU - Wuest, M. AU - Wang, M. AU - Wuest, F. PY - 2013 DA - 2013// TI - Radiotracers for molecular imaging of cyclooxygenase-2 (COX-2) enzyme JO - Curr Med Chem VL - 20 UR - https://doi.org/10.2174/09298673113206660260 DO - 10.2174/09298673113206660260 ID - Tietz2013 ER - TY - JOUR AU - Pacelli, A. AU - Greenman, J. AU - Cawthorne, C. AU - Smith, G. PY - 2014 DA - 2014// TI - Imaging COX-2 expression in cancer using PET/SPECT radioligands: current status and future directions JO - J Labelled Compd Radiopharm VL - 57 UR - https://doi.org/10.1002/jlcr.3160 DO - 10.1002/jlcr.3160 ID - Pacelli2014 ER - TY - JOUR AU - Laube, M. AU - Kniess, T. AU - Pietzsch, J. PY - 2013 DA - 2013// TI - Radiolabelled COX-2 inhibitors for non-invasive visualization of COX-2 expression and activity—a critical update JO - Molecules VL - 18 UR - https://doi.org/10.3390/molecules18066311 DO - 10.3390/molecules18066311 ID - Laube2013 ER - TY - JOUR AU - McCarthy, T. J. AU - Sheriff, A. U. AU - Graneto, M. J. AU - Talley, J. J. AU - Welch, M. J. PY - 2002 DA - 2002// TI - Radiosynthesis, in vitro validation, and in vivo evaluation of 18F-labeled COX-1 and COX-2 inhibitors JO - J Nucl Med VL - 43 ID - McCarthy2002 ER - TY - JOUR AU - Uddin, M. AU - Crews, B. AU - Ghebreselasie, K. AU - Huda, I. AU - Kingsley, P. AU - Ansari, M. PY - 2011 DA - 2011// TI - Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer JO - Can Prev Res VL - 4 UR - https://doi.org/10.1158/1940-6207.CAPR-11-0120 DO - 10.1158/1940-6207.CAPR-11-0120 ID - Uddin2011 ER - TY - JOUR AU - Kaur, J. AU - Tietz, O. AU - Bhardwaj, A. AU - Marshall, A. AU - Way, J. AU - Wuest, M. PY - 2015 DA - 2015// TI - Design, synthesis, and evaluation of an (18) F-labeled radiotracer based on celecoxib-NBD for positron emission tomography (PET) imaging of cyclooxygenase-2 (COX-2) JO - Chem Med Chem VL - 10 UR - https://doi.org/10.1002/cmdc.201500287 DO - 10.1002/cmdc.201500287 ID - Kaur2015 ER - TY - JOUR AU - Beswick, P. J. AU - Blackaby, A. P. AU - Bountra, C. AU - Brown, T. AU - Browning, K. AU - Campbell, I. B. PY - 2009 DA - 2009// TI - Identification and optimisation of a novel series of pyrimidine based cyclooxygenase-2 (COX-2) inhibitors. Utilisation of a biotransformation approach JO - Bioorg Med Chem Lett VL - 19 UR - https://doi.org/10.1016/j.bmcl.2009.02.089 DO - 10.1016/j.bmcl.2009.02.089 ID - Beswick2009 ER - TY - JOUR AU - Tietz, O. AU - Sharma, S. K. AU - Kaur, J. AU - Way, J. AU - Marshall, A. AU - Wuest, M. PY - 2013 DA - 2013// TI - Synthesis of three 18F-labelled cyclooxygenase-2 (COX-2) inhibitors based on a pyrimidine scaffold JO - Org Biomol Chem VL - 11 UR - https://doi.org/10.1039/c3ob41935e DO - 10.1039/c3ob41935e ID - Tietz2013 ER - TY - JOUR AU - Way, J. AU - Wuest, F. PY - 2013 DA - 2013// TI - Fully automated synthesis of 4-[18F]fluorobenzylamine based on borohydride/NiCl2 reduction JO - Nucl Med Biol VL - 40 UR - https://doi.org/10.1016/j.nucmedbio.2012.11.010 DO - 10.1016/j.nucmedbio.2012.11.010 ID - Way2013 ER - TY - JOUR AU - Debucquoy, A. AU - Devos, E. AU - Vermaelen, P. AU - Landuyt, W. AU - Weer, S. AU - Heuvel, F. PY - 2009 DA - 2009// TI - 18F-FLT and 18F-FDG PET to measure response to radiotherapy combined with celecoxib in two colorectal xenograft models JO - Int J Radiat Biol VL - 85 UR - https://doi.org/10.1080/09553000903072074 DO - 10.1080/09553000903072074 ID - Debucquoy2009 ER - TY - JOUR AU - Feldman, H. S. AU - Hartvig, P. AU - Wiklund, L. AU - Doucette, A. M. AU - Antoni, G. AU - Gee, A. AU - Ulin, J. AU - Langstrom, B. PY - 1997 DA - 1997// TI - Regional distribution of 11C-labeled lidocaine, bupivacaine, and ropivacaine in the heart, lungs, and skeletal muscle of pigs studied with positron emission tomography JO - Biopharm Drug Dispos. VL - 18 UR - https://doi.org/3.0.CO;2-H DO - 3.0.CO;2-H ID - Feldman1997 ER - TY - JOUR AU - Patel, S. K. AU - Beaino, W. AU - Anderson, C. J. AU - Janjic, J. M. PY - 2015 DA - 2015// TI - Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model JO - Clin Immunol VL - 160 UR - https://doi.org/10.1016/j.clim.2015.04.019 DO - 10.1016/j.clim.2015.04.019 ID - Patel2015 ER - TY - JOUR AU - Riendeau, D. AU - Percival, M. D. AU - Boyce, S. AU - Brideau, C. AU - Charleson, S. AU - Cromlish, W. AU - Ethier, D. AU - Evans, J. AU - Falgueyret, J. P. AU - Ford-Hutchinson, A. W. AU - Gordon, R. AU - Greig, G. AU - Gresser, M. AU - Guay, J. AU - Kargman, S. AU - Léger, S. AU - Mancini, J. A. AU - O’Neill, G. AU - Ouellet, M. AU - Rodger, I. W. AU - Thérien, M. AU - Wang, Z. AU - Webb, J. K. AU - Wong, E. AU - Chan, C. C. PY - 1997 DA - 1997// TI - Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor JO - Br J Pharmacol VL - 121 UR - https://doi.org/10.1038/sj.bjp.0701076 DO - 10.1038/sj.bjp.0701076 ID - Riendeau1997 ER - TY - JOUR AU - Chan, C. C. AU - Boyce, S. AU - Brideau, C. AU - Charleson, S. AU - Cromlish, W. AU - Ethier, D. AU - Evans, J. AU - Ford-Hutchinson, A. W. AU - Forrest, M. J. AU - Gauthier, J. Y. AU - Gordon, R. AU - Gresser, M. AU - Guay, J. AU - Kargman, S. AU - Kennedy, B. AU - Leblanc, Y. AU - Leger, S. AU - Mancini, J. AU - O’Neill, G. P. AU - Ouellet, M. AU - Patrick, D. AU - Percival, M. D. AU - Perrier, H. AU - Prasit, P. AU - Rodger, I. PY - 1999 DA - 1999// TI - Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles JO - J Pharmacol Exp Ther VL - 290 ID - Chan1999 ER - TY - JOUR AU - Zhang, Y. AU - Cheng, S. AU - Zhang, M. AU - Zhen, L. AU - Pang, D. AU - Zhang, Q. AU - Li, Z. PY - 2013 DA - 2013// TI - High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer JO - PLoS One. VL - 8 UR - https://doi.org/10.1371/journal.pone.0076147 DO - 10.1371/journal.pone.0076147 ID - Zhang2013 ER - TY - JOUR AU - Awara, W. M. AU - El-Sisi, E. A. AU - El-Sayad, M. E. AU - Goda, A. E. PY - 2004 DA - 2004// TI - The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin? JO - Pharmacol Res VL - 50 UR - https://doi.org/10.1016/j.phrs.2004.04.002 DO - 10.1016/j.phrs.2004.04.002 ID - Awara2004 ER - TY - JOUR AU - Weber, A. AU - Casini, A. AU - Heine, A. AU - Kuhn, D. AU - Supuran, C. T. AU - Scozzafava, A. PY - 2004 DA - 2004// TI - Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition JO - J Med Chem VL - 47 UR - https://doi.org/10.1021/jm030912m DO - 10.1021/jm030912m ID - Weber2004 ER - TY - JOUR AU - Grosch, S. AU - Maier, T. J. AU - Schiffmann, S. AU - Geisslinger, G. PY - 2006 DA - 2006// TI - Cyclooxygenase-2 (COX-2) independent anticarcinogenic effects of selective COX-2 inhibitors JO - J Nat Cancer Inst VL - 98 UR - https://doi.org/10.1093/jnci/djj206 DO - 10.1093/jnci/djj206 ID - Grosch2006 ER -